Document is current
Any future updates will be listed below
-
Authors
Holt, Hayley https://orcid.org/0000-0003-4153-7982
Jolliffe, David A.
Talaei, Mohammad https://orcid.org/0000-0002-6901-3665
Faustini, Sian
Vivaldi, Giulia https://orcid.org/0000-0003-0816-9276
Greenig, Matthew
Richter, Alex G.
Lyons, Ronan A. https://orcid.org/0000-0001-5225-000X
Griffiths, Christopher J.
Kee, Frank
Sheikh, Aziz
Davies, Gwyneth A.
Shaheen, Seif O.
Martineau, Adrian R.
-
Funding
Funding for this research was provided by:
Barts Charity, MGU0466
- License Information
-
More Information
Article History
Received: 25 May 2022
Accepted: 27 January 2023
First Online: 25 February 2023
Competing interests
: J.S. declares receipt of payments from Reach plc for news stories written about recruitment to, and findings of, the COVIDENCE UK study. A.S. is a member of the Scottish Government Chief Medical Officer’s COVID-19 Advisory Group and its Standing Committee on Pandemics. He is also a member of the UK Government’s NERVTAG’s Risk Stratification Subgroup. ARM declares receipt of funding in the last 36 months to support vitamin D research from the following companies who manufacture or sell vitamin D supplements: Pharma Nord Ltd, DSM Nutritional Products Ltd, Thornton & Ross Ltd and Hyphens Pharma Ltd. ARM also declares support for attending meetings from the following companies who manufacture or sell vitamin D supplements: Pharma Nord Ltd and Abiogen Pharma Ltd. ARM also declares participation on the Data and Safety Monitoring Board for the Chair, DSMB, VITALITY trial (Vitamin D for Adolescents with HIV to reduce musculoskeletal morbidity and immunopathology). ARM also declares unpaid work as a Programme Committee member for the Vitamin D Workshop. ARM also declares receipt of vitamin D capsules for clinical trial use from Pharma Nord Ltd, Synergy Biologics Ltd and Cytoplan Ltd. All other authors declare have no competing interests.
